Walkman

Tianjin Walkman Biomaterial Co., Ltd. (hereinafter referred to as the Company) was established in 2001. It is a company engaged in the research, design, production, sales, and service of orthopedic medical devices. The Company focuses on the field of orthopedic implants, with products including trauma, spine, and their corresponding surgical instruments. It has successively obtained professional certifications such as CE, ISO13485, FDA, and CNAS, and has been rated as a high-tech enterprise in Tianjin. With its strong economic strength, senior R&D capabilities, scientific management system, and forward-looking marketing strategy, the Company's sales network covers all over China and extends to many countries and regions in Asia-Pacific, the Middle East, and beyond.Tianjin Walkman takes "national innovation" as its mission and actively explores the innovative path of "medical-engineering integration." Relying on its strong internal technical R&D team and advanced production equipment, it has successively launched a series of innovative orthopedic products, such as the "Poly-locking Patella Fracture Reduction and Fixation Device (Patent No. ZL 2011 2 0255614.6)," "Anatomical Full Locking Hip Fixation Device (Patent No. ZL 2011 2 0144376.1)," and "Bridging Modular Fracture Internal Fixation Device (Patent No. ZL 2005 1 0010654.3)," which have received widespread clinical recognition and praise. Among them, the Bridging Modular Fracture Internal Fixation Device pioneered personalized orthopedic internal fixation products. In 2015, it was approved for a research project by the National Health and Family Planning Commission and won the Chinese Orthopaedic Association’s "COA 2015 Most Valuable Design Top 10" award. To date, it has completed more than 50,000 surgeries in over 700 hospitals across China, demonstrating excellent clinical outcomes.Currently, Tianjin Walkman is actively seeking out significant market opportunities brought about by technological advancements and transformations in the orthopedic industry. In future development, we will continue to uphold the corporate spirit of "scientific innovation, serving clinics" and provide high-quality products and considerate services to our colleagues in the orthopedic field, continuously striving to promote the vigorous development of China's orthopedic cause!